Dong Wha Pharm Co., Ltd.(KR:000020)
â‚©4,845.00-120.00 (-2.42%)
KR:000020
Dong Wha Pharm Co., Ltd. financials statements
â‚©4,845.00
At close:-120.00 (-2.42%)
Want to see KR:000020 full AI Analyst Report?
Dong Wha Pharm Co., Ltd. (000020) Ratios
Dong Wha Pharm Co., Ltd. Ratios
KR:000020's free cash flow for Q3 2026 was ₩19.46B. For the 2026 fiscal year, KR:000020's free cash flow was decreased by ₩-1.50B and operating cash flow was ₩20.96B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.07 | 1.77 | 2.24 | 3.01 | 3.31 |
| Quick Ratio | 0.59 | 1.11 | 1.57 | 2.39 | 2.77 |
| Cash Ratio | 0.07 | 0.19 | 0.68 | 0.45 | 0.91 |
| Solvency Ratio | 0.13 | 0.12 | 0.26 | 0.40 | 0.34 |
| Operating Cash Flow Ratio | 0.08 | -0.03 | 0.27 | 0.39 | 0.54 |
| Short-Term Operating Cash Flow Coverage | 0.18 | -0.13 | 1.99 | 11.69 | 8.01 |
| Net Current Asset Value | â‚© -22.93B | â‚© 19.85B | â‚© 79.78B | â‚© 145.06B | â‚© 132.53B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.16 | 0.08 | 0.01 | 0.03 |
| Debt-to-Equity Ratio | 0.31 | 0.26 | 0.13 | 0.02 | 0.03 |
| Debt-to-Capital Ratio | 0.24 | 0.21 | 0.11 | 0.02 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.11 | 0.04 | 0.00 | 0.01 |
| Financial Leverage Ratio | 1.69 | 1.66 | 1.52 | 1.27 | 1.29 |
| Debt Service Coverage Ratio | 0.21 | 0.72 | 2.67 | 12.80 | 6.65 |
| Interest Coverage Ratio | -0.18 | 6.23 | 82.15 | 80.85 | 58.72 |
| Debt to Market Cap | 0.59 | 0.43 | 0.11 | 0.01 | 0.02 |
| Interest Debt Per Share | 4401.14 | 3576.78 | 1712.38 | 254.13 | 429.08 |
| Net Debt to EBITDA | 4.97 | 2.48 | -0.52 | -0.72 | -1.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.96% | 46.09% | 52.73% | 53.17% | 50.97% |
| EBIT Margin | -0.16% | 1.95% | 9.65% | 7.56% | 9.32% |
| EBITDA Margin | 4.26% | 6.18% | 13.50% | 11.23% | 13.45% |
| Operating Profit Margin | -0.16% | 2.88% | 7.01% | 8.79% | 7.68% |
| Pretax Profit Margin | 1.21% | 1.48% | 10.23% | 6.78% | 9.05% |
| Net Profit Margin | 1.75% | 1.20% | 7.60% | 5.99% | 6.10% |
| Continuous Operations Profit Margin | 0.77% | 0.46% | 7.82% | 6.34% | 6.68% |
| Net Income Per EBT | 144.70% | 80.60% | 74.25% | 88.30% | 67.37% |
| EBT Per EBIT | -741.80% | 51.47% | 146.06% | 77.17% | 117.92% |
| Return on Assets (ROA) | 1.35% | 0.90% | 4.86% | 4.42% | 3.99% |
| Return on Equity (ROE) | 2.29% | 1.49% | 7.38% | 5.59% | 5.15% |
| Return on Capital Employed (ROCE) | -0.18% | 2.76% | 5.51% | 7.76% | 5.90% |
| Return on Invested Capital (ROIC) | -0.10% | 0.80% | 4.04% | 7.17% | 4.28% |
| Return on Tangible Assets | 1.55% | 1.04% | 5.40% | 4.58% | 4.16% |
| Earnings Yield | 4.98% | 3.19% | 9.45% | 7.95% | 4.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.45 | 4.62 | 5.58 | 4.87 | 4.80 |
| Payables Turnover | 6.86 | 6.45 | 5.43 | 7.17 | 8.39 |
| Inventory Turnover | 2.99 | 2.81 | 2.41 | 3.41 | 3.96 |
| Fixed Asset Turnover | 2.36 | 2.12 | 1.92 | 2.25 | 2.05 |
| Asset Turnover | 0.77 | 0.75 | 0.64 | 0.74 | 0.65 |
| Working Capital Turnover Ratio | 8.37 | 3.95 | 2.55 | 2.23 | 1.90 |
| Cash Conversion Cycle | 135.72 | 152.41 | 149.45 | 131.09 | 124.69 |
| Days of Sales Outstanding | 67.02 | 78.92 | 65.44 | 74.89 | 76.10 |
| Days of Inventory Outstanding | 121.89 | 130.10 | 151.18 | 107.10 | 92.08 |
| Days of Payables Outstanding | 53.19 | 56.60 | 67.17 | 50.90 | 43.49 |
| Operating Cycle | 188.92 | 209.02 | 216.62 | 181.99 | 168.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 562.05 | -144.43 | 1053.48 | 1055.70 | 1303.87 |
| Free Cash Flow Per Share | -1341.72 | -2816.47 | 101.89 | 329.83 | 407.36 |
| Dividend Paid and CapEx Coverage Ratio | 0.27 | -0.05 | 0.93 | 1.17 | 1.21 |
| Capital Expenditure Coverage Ratio | 0.30 | -0.05 | 1.11 | 1.45 | 1.45 |
| Operating Cash Flow Coverage Ratio | 0.13 | -0.04 | 0.62 | 4.38 | 3.14 |
| Operating Cash Flow to Sales Ratio | 0.03 | -0.01 | 0.08 | 0.09 | 0.12 |
| Free Cash Flow Yield | -21.47% | -44.71% | 0.97% | 3.56% | 2.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.94 | 31.39 | 10.58 | 12.57 | 22.58 |
| Price-to-Sales (P/S) Ratio | 0.35 | 0.38 | 0.80 | 0.75 | 1.38 |
| Price-to-Book (P/B) Ratio | 0.46 | 0.47 | 0.78 | 0.70 | 1.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.66 | -2.24 | 102.95 | 28.08 | 35.84 |
| Price-to-Operating Cash Flow Ratio | 11.12 | -43.62 | 9.96 | 8.77 | 11.20 |
| Price-to-Earnings Growth (PEG) Ratio | 0.36 | -0.39 | 0.31 | 0.91 | -0.60 |
| Enterprise Value Multiple | 13.22 | 8.56 | 5.44 | 5.98 | 8.99 |
| Enterprise Value | 279.68B | 245.96B | 265.21B | 228.62B | 354.45B |
| EV to EBITDA | 13.22 | 8.56 | 5.44 | 5.98 | 8.99 |
| EV to Sales | 0.56 | 0.53 | 0.73 | 0.67 | 1.21 |
| EV to Free Cash Flow | -7.46 | -3.15 | 94.01 | 25.04 | 31.49 |
| EV to Operating Cash Flow | 17.82 | -61.44 | 9.09 | 7.82 | 9.84 |
| Tangible Book Value Per Share | 11439.62 | 11472.36 | 12662.67 | 13113.58 | 12375.88 |
| Shareholders’ Equity Per Share | 13588.02 | 13470.34 | 13428.43 | 13165.23 | 12554.64 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.36 | 0.69 | 0.24 | 0.06 | 0.26 |
| Revenue Per Share | 17772.16 | 16771.58 | 13043.00 | 12299.08 | 10603.54 |
| Net Income Per Share | 310.98 | 200.71 | 991.05 | 736.42 | 646.68 |
| Tax Burden | 1.45 | 0.81 | 0.74 | 0.88 | 0.67 |
| Interest Burden | -7.42 | 0.76 | 1.06 | 0.90 | 0.97 |
| Research & Development to Revenue | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 |
| SG&A to Revenue | 0.22 | 0.22 | 0.40 | 0.23 | 0.19 |
| Stock-Based Compensation to Revenue | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.81 | -1.87 | 1.03 | 1.35 | 1.84 |
Currency in KRW
